Back to Search
Start Over
1054P A phase Ia study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of a modular CLDN18.2-targeting PG CAR-T therapy (IBI345) in patients with CLDN18.2+ solid tumors.
- Source :
-
Annals of Oncology . 2023 Supplement 2, Vol. 34, pS638-S638. 1p. - Publication Year :
- 2023
- Subjects :
- *PHARMACOKINETICS
*TUMORS
*SAFETY
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173098984
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.09.2193